home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

274 rows where filing_period = "third_quarter", filing_year = 2011 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 274 ✖

filing_year 1

  • 2011 · 274 ✖

filing_period 1

  • third_quarter · 274 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1144318 MARSHALL BRACHMAN 976e97e4-f83b-4a20-903f-b2aed96a399b Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2011 third_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2011-10-02T22:00:56.330000-04:00
1144331 MARSHALL BRACHMAN dd36764f-1fd6-45f0-9974-b35b2072a82d Q3 MARSHALL BRACHMAN 6848 CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE 2011 third_quarter MED reverse cardiac catheterization practice expense cuts HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2011-10-02T22:10:59.360000-04:00
1144484 TAKEDA PHARMACEUTICALS AMERICA, INC. 6b94c7f8-f4cb-4523-9af6-5c84d4f80955 Q3 TAKEDA PHARMACEUTICALS AMERICA, INC. 57954 TAKEDA PHARMACEUTICALS AMERICA INC 2011 third_quarter MED Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239); depression screening, end stage renal disease; Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE,Treasury, Dept of   400000 0 0 2011-10-03T13:54:18.780000-04:00
1144716 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 832e7946-b07c-4123-949a-2892f9fde929 Q3 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2011 third_quarter MED all issues relating to pharmaceutical labeling   25000   0 0 2011-10-04T13:05:54.343000-04:00
1144722 THE HARRIS FIRM 6b137de3-e6d0-4171-91f6-49f72eb0d2c2 Q3 THE HARRIS FIRM 68376 DIRECT MESSAGE LAB 2011 third_quarter MED Regarding funding for FY 11 pertaining to software communication system for chronic disease management Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-04T13:26:58.840000-04:00
1144766 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 4c48f14c-b905-43bf-aca0-8f03e3035426 Q3 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2011 third_quarter MED AACC joined with Members of the Clinical Laboratory Coalition in writing to Members of the House and Senate in opposing the adoption of a clinical laboratory co-payment as part of any debt reduction package. AACC joined with Members of the Clinical Laboratory Coalition in writing to members of the Joint Select Committee on Deficit Reduction in opposition to a clinical laboratory co-payment as part of any debt reduction package. AACC wrote separately to House and Senate Members of the Joint Select Committee on Deficit Reduction to oppose the establishment of a clinical laboratory co-payment as part of any debt reduction package. HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-04T15:02:34.957000-04:00
1144849 AMERICAN COLLEGE OF CLINICAL PHARMACY 34947c73-2a84-4032-9ca2-13ecde8cf4b2 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2011 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   59600 0 0 2011-10-05T09:52:10.183000-04:00
1145271 GRIZZLE COMPANY 2221c236-6dc6-4019-a109-21deac805794 Q3 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2011 third_quarter MED Request support for NIH grant application HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-06T14:41:45.107000-04:00
1145310 ASSN OF MEDICAL DEVICE REPROCESSORS 2dae1811-1072-469a-8f14-42947d0344d3 Q3 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2011 third_quarter MED Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2011-10-06T15:30:16.683000-04:00
1145525 CEPHEID aee4906c-1b89-4370-a926-ba1704c67c80 Q3 CEPHEID 400270233 CEPHEID 2011 third_quarter MED See page five Lobbying Issues: molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues HR 436/ S 17, Protect Medical Innovation Act of 2011 HR 488, Save Our Medical Devices Act of 2011 HR 755, Investing in Our Future Act of 2011 HR 965/ S 1211, Preservation of Antibiotics for Medical Treatment Act of 2011 HR 2182 Generating Antibiotic Incentives Now (GAIN) S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE   40000 0 0 2011-10-07T14:02:11.433000-04:00
1145554 DALRYMPLE & ASSOCIATES, LLC 5dfd0530-8a0b-4713-9d2e-b86105d8a8a8 Q3 DALRYMPLE & ASSOCIATES, LLC 5073 DISCOVERY LABORATORIES 2011 third_quarter MED Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 20000   0 0 2011-10-07T14:40:34.010000-04:00
1145561 DALRYMPLE & ASSOCIATES, LLC c72e8950-7683-4433-82f7-e49d60cf335e Q3 DALRYMPLE & ASSOCIATES, LLC 5073 BRIGHTON BIOTECH, INC. 2011 third_quarter MED Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 16000   0 0 2011-10-07T14:54:35.007000-04:00
1145569 DALRYMPLE & ASSOCIATES, LLC 251b9293-0b6c-44e1-a563-4fd9c590ee7f Q3 DALRYMPLE & ASSOCIATES, LLC 5073 EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) 2011 third_quarter MED Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 46000   0 0 2011-10-07T15:01:38.040000-04:00
1145584 DALRYMPLE & ASSOCIATES, LLC 53f3c3bd-24c3-41fc-9e7a-4139c11e1744 Q3 DALRYMPLE & ASSOCIATES, LLC 5073 SANOFI PASTEUR 2011 third_quarter MED Vaccine research and development legislation, funding, appropriations and oversight. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office 46000   0 0 2011-10-07T15:13:50.350000-04:00
1145714 BEN BARNES GROUP LP 033a2194-e133-44e8-88ec-e370a868f0bc Q3 BEN BARNES GROUP LP 5415 FAIR LABORATORY PRACTICES ASSOCIATION 2011 third_quarter MED Bring attention to prevention of unfair billing practices by laboratories for Medicare services HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-08T14:19:11.060000-04:00
1145722 BEN BARNES GROUP LP 619c48d5-e6df-4ef3-b0e6-d818720a4cf7 Q3 BEN BARNES GROUP LP 5415 HUNTSMAN CANCER INSTITUTE 2011 third_quarter MED Medical Research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-08T15:08:14.437000-04:00
1145794 FEDERAL SOLUTIONS, LLC 5da5ad5d-8592-4a5f-bf61-c22c2e0b2695 Q3 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2011 third_quarter MED Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research, education, and development HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-10T10:21:30.523000-04:00
1145810 FEDERAL SOLUTIONS, LLC 7710b85b-4a2e-4fd5-a684-1b2cf0d9968d Q3 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2011 third_quarter MED Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2011-10-10T10:30:34.057000-04:00
1146244 WAKE FOREST UNIVERSITY HEALTH SCIENCES 5b2d1981-5519-43cd-865d-7ef2e3043ff8 Q3 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2011 third_quarter MED NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) America Invents Act HR1249 Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA)   160000 0 0 2011-10-11T10:51:25.287000-04:00
1146318 HOLLAND & KNIGHT LLP bcea67cd-d33e-429b-bf27-1a188807fec8 Q3 HOLLAND & KNIGHT LLP 18466 SHIRE PHARMACEUTICALS, INC 2011 third_quarter MED Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products. Participate in FDA stakeholder meetings re Prescription Drug User Fee program. Met with FDA officials regarding programs to support development of products for rare diseases. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-11T11:32:09.710000-04:00
1146321 HOLLAND & KNIGHT LLP df45bb38-c683-42c7-acea-e5c0bcbd514e Q3 HOLLAND & KNIGHT LLP 18466 ALLIANCE FOR REGENERATIVE MEDICINE 2011 third_quarter MED Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA. Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE 80000   0 0 2011-10-11T11:32:10.710000-04:00
1146643 NATIONAL VENTURE CAPITAL ASSOCIATION 32208465-8c64-4443-8a60-8ee06580b950 Q3 NATIONAL VENTURE CAPITAL ASSOCIATION 21687 NATIONAL VENTURE CAPITAL ASSOCIATION 2011 third_quarter MED Personalized medicine: working with Congress to establish a regulatory approval and reimbursement path for advanced diagnostic products. NVCA submitted comments to FDA and CMS on their FDA/CMA parallel review draft proposal Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office   506930 0 0 2011-10-11T15:36:10.037000-04:00
1147027 THE PETRIZZO GROUP, INC. fa287894-a420-44b6-865a-af8e892638d2 Q3 THE PETRIZZO GROUP, INC. 305932 FATE THERAPEUTICS, INC. 2011 third_quarter MED Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-12T11:31:28.647000-04:00
1147217 THE PETRIZZO GROUP, INC. 3a26c701-7fdb-46c7-9013-4c48baf81f74 Q3 THE PETRIZZO GROUP, INC. 305932 SEATTLE CANCER CARE ALLIANCE 2011 third_quarter MED Advocated for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-12T13:25:19.457000-04:00
1147235 THE PETRIZZO GROUP, INC. 203cd8bb-e3ac-417c-80f1-be21e6b479f8 Q3 THE PETRIZZO GROUP, INC. 305932 SAGE THERAPEUTICS, INC. 2011 third_quarter MED Advocated for federal funding to support development of neuroactive steroids to yield therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-12T13:34:30.983000-04:00
1147245 THE PETRIZZO GROUP, INC. bc7e9ef2-b566-44a4-8696-fbcf758096b1 Q3 THE PETRIZZO GROUP, INC. 305932 SEATTLE BIOMEDICAL RESEARCH INSTITUTE 2011 third_quarter MED Advocated for funding to support next-generation drug development for Leishmaniasis. HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-12T13:45:36.140000-04:00
1147280 THE PETRIZZO GROUP, INC. 307c8298-4f44-4c2a-b289-f4fa15e1e83b Q3 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2011 third_quarter MED Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011federal funding. Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-12T14:04:58.547000-04:00
1147327 PALMETTO GROUP d1674a51-1932-49f4-888a-6fe424e0603d Q3 PALMETTO GROUP 18570 INTERNATIONAL AIDS VACCINE INITIATIVE 2011 third_quarter MED Federal Funding of AIDS vaccine S.1601 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012 SENATE     0 0 2011-10-12T14:37:28.943000-04:00
1147376 AMERICAN ASSOCIATION OF COLLEGES OF NURSING e19cb891-9059-416e-bb6d-e422e9e18546 Q3 AMERICAN ASSOCIATION OF COLLEGES OF NURSING 66911 AMERICAN ASSOCIATION OF COLLEGES OF NURSING 2011 third_quarter MED Lobbied Members of Congress for additional nursing research funding in the FY 2012 LHHS Appropriations through the National Institutes of Health, National Institute of Nursing Research, and the Agency for Healthcare Research and Quality. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Indian Health Service,Natl Institutes of Health (NIH),SENATE   25000 0 0 2011-10-12T15:29:49.017000-04:00
1147472 MEHLMAN CONSULTING, INC. 3f3e16db-cac7-41d0-859c-285ce91eef01 Q3 MEHLMAN CONSULTING, INC. 284950 NATIONAL VENTURE CAPITAL ASSOCIATION 2011 third_quarter MED FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs. HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 60000   0 0 2011-10-12T16:48:45.153000-04:00
1147665 FAEGRE BAKER DANIELS CONSULTING 58fc1020-4a8d-4530-80cc-f96708bd64d6 Q3 FAEGRE BAKER DANIELS CONSULTING 34158 ARTHRITIS FOUNDATION 2011 third_quarter MED NIH RESEARCH, CDC PUBLIC HEALTH, MEDICARE, CHILDREN'S HEALTH HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-13T10:37:44.883000-04:00
1148198 FRANCIS EDWARD & CRONIN, INC. c4406b28-186e-4e36-9be1-8fd275aa764a Q3 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2011 third_quarter MED Legislation and issues related to Alzheimer's Disease Research Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,SENATE,White House Office 10000   0 0 2011-10-13T15:22:10.263000-04:00
1148353 EDWARDS WILDMAN PALMER LLP 8b30ccf2-9c78-4d72-8a64-f3e2ef40c9f6 Q3 EDWARDS WILDMAN PALMER LLP 400309447 ELUSYS THERAPEUTICS, INC. 2011 third_quarter MED Assisting with PAHPA reauthorization. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-13T16:16:41.777000-04:00
1148409 PARRY, ROMANI, DECONCINI & SYMMS 78698d2e-c673-4e59-8e7a-2f3ed06775c0 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2011 third_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011 - Support funding for medical treatment for HIV positive patients. Support appropriate funding for the ADAP program. Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-13T16:57:24.403000-04:00
1148707 WASHINGTON UNIVERSITY IN ST. LOUIS 829b04ee-2c72-4971-9e4f-52ac45b859b7 Q3 WASHINGTON UNIVERSITY IN ST. LOUIS 40031264 WASHINGTON UNIVERSITY IN ST LOUIS 2011 third_quarter MED General advocacy for NIH research, genomics research, and improved conflict of interest policies. Advocacy in support of clear, productive federal stem cell research guidelines. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   40000 0 0 2011-10-14T10:37:48.800000-04:00
1148728 AMERICAN DIABETES ASSOCIATION 6290d40a-07c8-49cc-8810-9d234f4e9229 Q3 AMERICAN DIABETES ASSOCIATION 2230 AMERICAN DIABETES ASSOCIATION 2011 third_quarter MED H.R. 4808, the Stem Cell Enhancement Act. Support bill. Legislation codifies the Obama Administrations Executive Order and National Institutes of Health guidelines regarding federal funding of human embryonic stem cell research. (Lobbyists used: Lisa Cox) Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE   141000 0 0 2011-10-14T10:49:18.127000-04:00
1148831 FAEGRE BAKER DANIELS CONSULTING 0ef6ef17-6e92-472d-a1c6-ac03948e1563 Q3 FAEGRE BAKER DANIELS CONSULTING 34158 LEARNING & EDUCATION ACADEMIC RESEARCH NETWORK 2011 third_quarter MED NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT RESEARCH GRANTS Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE 10000   0 0 2011-10-14T11:33:09.453000-04:00
1149226 CORNERSTONE GOVERNMENT AFFAIRS, INC. 2ec0df53-b1e8-4170-b1bb-4cf6d169e653 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 PATH 2011 third_quarter MED Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-14T13:58:48.053000-04:00
1149333 THE PETRIZZO GROUP, INC. b976e1dc-064b-47d3-b6ce-e08626211ac4 Q3 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2011 third_quarter MED Advocated for legislation to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-14T14:32:36.037000-04:00
1149473 FOLEY & LARDNER LLP f8628f61-0660-41d2-96ec-1d465817c7cc Q3 FOLEY & LARDNER LLP 15042 ROMARK LABORATORIES, LC 2011 third_quarter MED Sale of new anti-viral drug Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-14T15:28:47.940000-04:00
1149483 FOLEY & LARDNER LLP 97e95db4-6f69-4598-9d0e-d16d83dd6683 Q3 FOLEY & LARDNER LLP 15042 PHOENIX NUCLEAR LABS LLC 2011 third_quarter MED Legislation to promote development of radio-isotopes for medical diagnostics and therapy Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-14T15:32:56.410000-04:00
1149550 FOLEY & LARDNER LLP 489d5dff-aad1-44da-bd87-fe44dd9b156c Q3 FOLEY & LARDNER LLP 15042 FLUGEN, INC. 2011 third_quarter MED Funding for vaccine research and development and vaccine delivery product. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-14T15:46:32.113000-04:00
1149662 TCH GROUP, LLC c4a46ded-605e-4858-b45e-587c99f6beaf Q3 TCH GROUP, LLC 51478 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2011 third_quarter MED General discussion regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-14T16:43:46.377000-04:00
1149707 GROUP HEALTH COOPERATIVE 0c8bac11-72d1-48c5-9834-62cb90e1ac94 Q3 GROUP HEALTH COOPERATIVE 17022 GROUP HEALTH COOPERATIVE 2011 third_quarter MED Issues related to health reform legislation and regulation including Medicare Advantage; insurance regulation changes; insurance taxes; health cooperatives; health systems reserach topics such as the patient-centered medical home; the Patient Protection and Affordable Care Act. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office   110000 0 0 2011-10-14T16:57:08.283000-04:00
1149865 THE CJR GROUP, INC. 58e745a6-de76-4797-bca3-610ec40fe895 Q3 THE CJR GROUP, INC. 288293 STERIS CORPORATION 2011 third_quarter MED Biomedical issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-15T09:57:41-04:00
1149869 THE CJR GROUP, INC. 98f66d88-e0b0-44d9-908e-39f6ad517a6c Q3 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2011 third_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-15T10:03:42.827000-04:00
1149926 BEN BARNES GROUP LP 561040be-9752-4a6f-a717-9ef08ec177cc Q3 BEN BARNES GROUP LP 5415 OKLAHOMA RESEARCH MEDICAL FOUNDATION 2011 third_quarter MED Medical Research SENATE 20100   0 0 2011-10-15T14:05:06.447000-04:00
1149996 PERSONALIZED MEDICINE COALITION 33733fdc-3fa5-48c0-8ad0-c101c56377dc Q3 PERSONALIZED MEDICINE COALITION 40046362 PERSONALIZED MEDICINE COALITION 2011 third_quarter MED CER, CMS, Coverage of Genetic Testing Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   6499 0 0 2011-10-15T22:04:07.350000-04:00
1150045 AKIN GUMP STRAUSS HAUER & FELD 3e5e0971-47ae-4066-bcc2-dadc8bf82e6f Q3 AKIN GUMP STRAUSS HAUER & FELD 682 NOVARTIS CORPORATION 2011 third_quarter MED Issues related to the importance of vaccines HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2011-10-16T15:55:25.207000-04:00
1150596 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 29be2f14-bdd6-49db-975d-37b3414664f7 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ONYX PHARMACEUTICALS 2011 third_quarter MED Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-17T11:27:41.357000-04:00
1150688 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9f449e49-7144-492d-afca-32c4abadf2da Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NAVIGENICS, INC. 2011 third_quarter MED Oversight and regulation of genetic testing. Direct to consumer genetic testing. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-17T11:51:25.530000-04:00
1150716 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b72a1368-daff-4b5b-86e3-b2f75ffbc94d Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TETHYS BIOSCIENCE 2011 third_quarter MED Regulation of laboratory developed tests. No Bill #: BETTER Patient Care Act Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-17T11:59:37.277000-04:00
1150735 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. cc03d1f0-ab20-4358-a88a-c1709d79b437 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2011 third_quarter MED Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, American Invents Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE 30000   0 0 2011-10-17T12:10:47.873000-04:00
1150865 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 011af3e5-b0d4-4a7f-95c2-7488af7a44c9 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2011 third_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2011-10-17T12:53:39.483000-04:00
1150890 AMERICAN ASSOCIATION FOR CANCER RESEARCH 19a6ea21-be07-46dc-8ed6-dd025ae04b73 Q3 AMERICAN ASSOCIATION FOR CANCER RESEARCH 400601833 AMERICAN ASSOCIATION FOR CANCER RESEARCH 2011 third_quarter MED upcoming reauthorization of Prescription Drug User Fee Act and Medical Device User Fee Act HOUSE OF REPRESENTATIVES,SENATE   15000 0 0 2011-10-17T12:59:51.013000-04:00
1150906 CALIFORNIA LIFE SCIENCES d9a45920-ecaa-42b0-a281-2d0831b1b6dd Q3 CALIFORNIA LIFE SCIENCES 7758 CALIFORNIA LIFE SCIENCES 2011 third_quarter MED Support NIH funding. HOUSE OF REPRESENTATIVES,SENATE   140000 0 0 2011-10-17T13:01:54.560000-04:00
1150908 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3ea52269-8e4a-4232-b2f3-6227f856e7fe Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2011 third_quarter MED Research in hematology. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2011-10-17T13:02:55.513000-04:00
1150925 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 284930a8-0040-49c5-a746-ea87f306d2ae Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION OF AMERICA'S BLOOD BANKS 2011 third_quarter MED Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-17T13:07:03.683000-04:00
1150944 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d5f5a18f-f54e-4121-b136-cfee33319b54 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION 2011 third_quarter MED S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2011-10-17T13:17:14.450000-04:00
1150962 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 040042d9-510b-4303-99eb-596a7eb418b4 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION 2011 third_quarter MED S. 1599, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research HR 2123/S 1167, Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-17T13:20:19.687000-04:00
1151050 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 208b4c5c-afbe-45b1-beee-01356877a028 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2011 third_quarter MED S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, Tuberous Sclerosis HR 1473, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2011-10-17T14:05:49.277000-04:00
1151070 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 87b2f34d-92b1-4eff-8e09-d4f3df1fdd02 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 SAGE PUBLICATIONS, INC. 2011 third_quarter MED No Bill#, Federal Research Public Access Act National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, NIH Open Access Policy, Department of Education Title II Funding No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-17T14:09:54.977000-04:00
1151112 BALCH & BINGHAM, LLP 66e7e4b3-9a6d-428e-a417-d5b980417981 3T BALCH & BINGHAM, LLP 5197 BIOCRYST PHARMACEUTICALS INC 2011 third_quarter MED Programs, regulations and legislation pertaining to: Project Bioshield; Federal pandemic preparedness and response; the Biomedical Advanced Research and Development Authority; the Food & Drug Administration. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2011-10-17T14:21:15.357000-04:00
1151137 PARRY, ROMANI, DECONCINI & SYMMS 9e878fe1-f6fa-4160-ad8f-1275a08de954 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2011 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-10-17T14:27:27.150000-04:00
1151186 PARRY, ROMANI, DECONCINI & SYMMS 128133c7-36ec-4fb9-8aa1-c54f21cf7ff1 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2011 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2011-10-17T14:36:45.987000-04:00
1151287 POLICY DIRECTIONS INC. 35ac5cb3-41cd-4fa4-a552-c1c7eddd7c9c Q3 POLICY DIRECTIONS INC. 31747 BAYLOR COLLEGE OF MEDICINE 2011 third_quarter MED S. 606 and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment. HR 528 - Neglected Infections of Impoverished Americans Act of 2011. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-17T14:56:25.567000-04:00
1151291 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 13671ab3-e55e-48b6-824d-c88b2a18c0fe Q3 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 1375 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 2011 third_quarter MED Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ) Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE   7087 0 0 2011-10-17T14:59:28.850000-04:00
1151424 PARRY, ROMANI, DECONCINI & SYMMS 083d9071-19ea-483c-bfd0-464b908be417 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2011 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-10-17T15:22:15.357000-04:00
1151450 PARRY, ROMANI, DECONCINI & SYMMS 9b1a94b1-063d-442e-9416-24e4290aeeb5 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2011 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-10-17T15:28:25.090000-04:00
1151517 PARRY, ROMANI, DECONCINI & SYMMS 5d125bb2-465d-433b-bbe4-a640a626165f Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2011 third_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2011-10-17T15:37:42.997000-04:00
1151574 THE CORMAC GROUP, LLC f3e7b773-a448-4821-9bdb-a26fb6a5da35 Q3 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2011 third_quarter MED Appropriations, DOD HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2011-10-17T15:56:11.530000-04:00
1151632 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f81d38f5-35a9-4e6e-bf20-78eafbf9f695 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2011 third_quarter MED Appropriations and Authorization legislation for FY 2012 in health care HR3070/S.1599 Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2011-10-17T16:10:30.870000-04:00
1151671 PARRY, ROMANI, DECONCINI & SYMMS 6265b7ba-762d-4d2b-9318-74c16548ca86 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2011 third_quarter MED General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-17T16:25:46.260000-04:00
1151682 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 085b22e0-e9e7-4b62-8fe4-00cb9248c010 3A CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2011 third_quarter MED Appropriations and Authorization legislation for FY 2012 in health care HR3070/S.1599 Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2011-10-17T16:28:49.560000-04:00
1151687 FAEGRE DRINKER BIDDLE & REATH LLP 6b4c5ba0-469d-44e1-a947-e42ab05cea35 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2011 third_quarter MED Public Health Programs for Infectious and Tropical Disease; Issues related to Neglected Disease Product Approval; H.R. 528 - Neglected Infections of Impoverished Americans Act; CDC Infection and Vector Borne Disease Programs; S. Con. Res. 115 - World Malaria Day Resolution; S. 606 - Creating Hope Act of 2011; H.R. 2144 - 21st Century Global Technology Act. Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID) 30000   0 0 2011-10-17T16:29:51.230000-04:00
1151693 FAEGRE DRINKER BIDDLE & REATH LLP 64aacadc-beab-4af9-aa39-d777724f4eca Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 RIVERAIN MEDICAL 2011 third_quarter MED Increasing awareness of lung cancer and making it a public health priority Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-17T16:32:55.747000-04:00
1151704 FAEGRE DRINKER BIDDLE & REATH LLP 83a252ac-333e-41c4-a1b4-5024059ed668 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREVENT BLINDNESS 2011 third_quarter MED Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2011-10-17T16:35:00.823000-04:00
1151793 LATHAM & WATKINS LLP b551e569-42f3-415c-87ae-a5accbc0f882 Q3 LATHAM & WATKINS LLP 22201 BOSTON SCIENTIFIC CORPORATION 2011 third_quarter MED Congressional oversight of the Food and Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-17T16:53:39.997000-04:00
1151796 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5151403a-f776-484b-9551-ac9ad4618b05 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 COOLEY'S ANEMIA FOUNDATION 2011 third_quarter MED Drug review and approval process Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-17T16:53:41.293000-04:00
1151810 INFECTIOUS DISEASES SOCIETY OF AMERICA 36c5b0ec-c9e1-4e03-a0fc-2548f1e67945 Q3 INFECTIOUS DISEASES SOCIETY OF AMERICA 54836 INFECTIOUS DISEASES SOCIETY OF AMERICA 2011 third_quarter MED Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; and support for evidence-based decision making. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)   102889 0 0 2011-10-17T16:54:45.730000-04:00
1151844 FAEGRE DRINKER BIDDLE & REATH LLP ad0bab1b-5c36-4274-90e1-a79aa0e18b05 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 SMITH & NEPHEW, INC. 2011 third_quarter MED Issues Related to Arthritis. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Veterans Affairs, Dept of (VA) 50000   0 0 2011-10-17T16:59:59.167000-04:00
1151882 FAEGRE DRINKER BIDDLE & REATH LLP 4f0d7d00-ab66-4f98-888f-e7d6a380859a Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREECLAMPSIA FOUNDATION 2011 third_quarter MED Preeclampsia Research; National Health Calendar. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH) 10000   0 0 2011-10-17T17:03:11.637000-04:00
1151920 FAEGRE DRINKER BIDDLE & REATH LLP 1428fc21-f0e9-4d83-a8d5-d655beeb4b33 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2011 third_quarter MED Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-17T17:07:25.370000-04:00
1151961 FAEGRE DRINKER BIDDLE & REATH LLP 3f5d9940-36f2-4aee-8b3b-dc280a6aa31c Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 SPINA BIFIDA ASSOCIATION 2011 third_quarter MED Spina Bifida Research and Awareness and Access to Care; Medical Device User Fee Act. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 40000   0 0 2011-10-17T17:15:46.650000-04:00
1152177 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 820c60ce-4f5a-4ea4-8b0f-4e97168636c6 Q3 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2011 third_quarter MED No bill #: Advocate for disability and rehabilitation prioirities of the Patient Centered Outcomes Research Institute, espcially regarding comparative effectiveness research. Advocate for elevation of the National Center for Medical Rehabilitation Research within the National Institutes of Health. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   100000 0 0 2011-10-17T18:21:09.683000-04:00
1152546 VAN SCOYOC ASSOCIATES 1619f355-69df-4b5a-a3df-90bdf7e0071b Q3 VAN SCOYOC ASSOCIATES 39837 CORPORATE FRIENDS OF CDC, INC. 2011 third_quarter MED No lobbying activity. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2011-10-18T06:19:15.483000-04:00
1152787 SRI INTERNATIONAL 2e9f7b26-aa5d-4f2b-9eaa-f068cebbc6f9 Q3 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2011 third_quarter MED FY12 House and Senate Defense Appropriations (HR 2219) FY12 House and Senate Defense Authorizations (HR 1540/S 1253) Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405) HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2011-10-18T09:40:53.100000-04:00
1152925 MCDERMOTT WILL & SCHULTE LLP 3bf1a73b-902a-4235-ab5d-c840764d4243 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 COALITION FOR 21ST CENTURY MEDICINE 2011 third_quarter MED Issues concerning regulation of laboratory tests. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2011-10-18T10:10:48.797000-04:00
1152995 MCDERMOTT WILL & SCHULTE LLP 2b095093-1d54-4d83-9329-946b69a71fdd Q3 MCDERMOTT WILL & SCHULTE LLP 24338 GENOMIC HEALTH INC 2011 third_quarter MED FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2011-10-18T10:20:19.173000-04:00
1153072 DENNY MILLER ASSOCIATES 800182f1-4d4f-4ce8-afc7-7c8cf281ec33 Q3 DENNY MILLER ASSOCIATES 25328 CELL THERAPEUTICS 2011 third_quarter MED FDA appeal process for new drug applications. FDA process for approving clinical trials for new drug applications. Federal support for biotechnology companies. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-18T10:26:49.823000-04:00
1153186 BLANK ROME GOVERNMENT RELATIONS 8a858f76-c937-4718-bdab-d786c9a08bee Q3 BLANK ROME GOVERNMENT RELATIONS 6325 SELECT GREATER PHILADELPHIA (FORMERLY LISTED AS THE CEO COUNCIL FOR GROWTH) 2011 third_quarter MED Issues relating to laboratory space Centers For Disease Control & Prevention (CDC) 20000   0 0 2011-10-18T10:41:37.150000-04:00
1153995 DENNY MILLER ASSOCIATES e7321ce9-c751-422d-84ce-8c6334d72b4a Q3 DENNY MILLER ASSOCIATES 25328 SABEY CORPORATION 2011 third_quarter MED Oversight and implementation of the Patient Protection and Affordable Care Act (PL 111-148), provisions relating to the Center for Medicare and Medicaid Innovation grant program. Federal grant funding through the Department of Health and Human Services. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2011-10-18T13:02:07.807000-04:00
1154064 GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC) 659ebcdc-74d1-41a5-94ae-6f55c989bc2a Q3 GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC) 33124 IMX MEDICAL MANAGEMENT SERVICES 2011 third_quarter MED No specific legislative activities - .Continued to meet with members of Pennsylvania Congressional delegation to brief them on IMX's efforts to have their medical evaluation services given consideration by the Department of Veterans Affairs and the Department of Defense. Also held meetings with officials at Department of Veterans Affairs and Department of defense to discuss their procurement procedures for additional medical services. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 5000   0 0 2011-10-18T13:10:32.633000-04:00
1154072 PARKINSON'S ACTION NETWORK a83a85b1-4e0a-444f-acc8-a14f0d11a1c4 Q3 PARKINSON'S ACTION NETWORK 285676 PARKINSON'S ACTION NETWORK 2011 third_quarter MED H.R. 2595/S.425, "The National Neurological Diseases Surveillance System Act," all sections; "all sections relating to the National Insitutes of Health (NIH), Cures Acceleration Network, and the National Center for Advancing Translational Sciences"; "Department of Defense Appropriations," sec. related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) progarm; Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012," all sections FDA; Prescription Drug User Fee Act (PDUFA) V; Medical Device User Fee Act (MDUFA) IV; the Balanced Budget Act of 1997 (sections related to amending Medicare therapy caps). HOUSE OF REPRESENTATIVES,SENATE     0 0 2011-10-18T13:11:35.633000-04:00
1154080 CASSIDY & ASSOCIATES, INC. 1146836b-34ef-4f46-9230-16c6bdd0edb3 Q3 CASSIDY & ASSOCIATES, INC. 8453 LINDE NORTH AMERICA, INC. 2011 third_quarter MED Legislation related to the Food and Drug Administration HR2227, the Medical Gas Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-18T13:12:38.837000-04:00
1154192 DENNY MILLER ASSOCIATES 6ac6391f-ca11-4dea-8cbb-a1bd5ff1d941 Q3 DENNY MILLER ASSOCIATES 25328 ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER 2011 third_quarter MED S 1599, Labor, Health and Human Services, and Education Appropriations Bills, FY 2012, Title II, provisions relating to rural health care. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2011-10-18T13:32:24.037000-04:00
1154253 FAEGRE DRINKER BIDDLE & REATH LLP 5abcd4be-349c-415a-9cdb-60cddbf83f39 Q3 FAEGRE DRINKER BIDDLE & REATH LLP 12631 NATIONAL PSORIASIS FOUNDATION 2011 third_quarter MED H.R. 2033/S.1107 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; Psoriasis Data Collection. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,White House Office 50000   0 0 2011-10-18T13:39:49.900000-04:00
1154300 BROWNSTEIN HYATT FARBER SCHRECK, LLP 40375ee4-b261-4dc2-b062-3306941d1e98 Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ABBOTT LABORATORIES 2011 third_quarter MED Healthcare reform   60000   0 0 2011-10-18T13:49:13.727000-04:00
1154410 PARALYZED VETERANS OF AMERICA 22972ccc-8af4-40dc-ba68-1924775b590d Q3 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2011 third_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   81128 0 0 2011-10-18T14:09:01.777000-04:00
1154628 MCDERMOTT WILL & SCHULTE LLP 0e66da02-3012-4a12-9b4c-ceab8527cda8 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2011 third_quarter MED Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2011-10-18T14:31:28.007000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2178.738ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API